P/E ratio for 1-800-PetMeds (PETS)
P/E ratio as of September 2023 (TTM): -66.1
According to 1-800-PetMeds 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -66.0511. At the end of 2021 the company had a P/E ratio of 23.4.
P/E ratio history for 1-800-PetMeds from 2001 to 2022
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2021 | 23.4 | 12.35% |
| 2020 | 20.8 | 10.64% |
| 2019 | 18.8 | 64.22% |
| 2018 | 11.5 | -56.94% |
| 2017 | 26.6 | 24.56% |
| 2016 | 21.4 | 24.63% |
| 2015 | 17.1 | 2.58% |
| 2014 | 16.7 | -8.57% |
| 2013 | 18.3 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 CVS Health CVS | 31.0 | -146.95% | 🇺🇸 USA |
 Rite Aid
RAD | -0.0248 | -99.96% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.